These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18569015)

  • 21. Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease.
    Shen XM; Xia B; Wrona MZ; Dryhurst G
    Chem Res Toxicol; 1996; 9(7):1117-26. PubMed ID: 8902266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic inhibition of respiration in brain mitochondria by nitric oxide and dihydroxyphenylacetic acid (DOPAC). Implications for Parkinson's disease.
    Nunes C; Almeida L; Laranjinha J
    Neurochem Int; 2005 Aug; 47(3):173-82. PubMed ID: 15893407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.
    Cai X; Jia H; Liu Z; Hou B; Luo C; Feng Z; Li W; Liu J
    J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors.
    Seaton TA; Cooper JM; Schapira AH
    Brain Res; 1997 Nov; 777(1-2):110-8. PubMed ID: 9449419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta.
    Dada LA; Chandel NS; Ridge KM; Pedemonte C; Bertorello AM; Sznajder JI
    J Clin Invest; 2003 Apr; 111(7):1057-64. PubMed ID: 12671055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease.
    Bharath S; Andersen JK
    Antioxid Redox Signal; 2005; 7(7-8):900-10. PubMed ID: 15998245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease.
    Offen D; Ziv I; Sternin H; Melamed E; Hochman A
    Exp Neurol; 1996 Sep; 141(1):32-9. PubMed ID: 8797665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain.
    Khan FH; Saha M; Chakrabarti S
    Brain Res; 2001 Mar; 895(1-2):245-9. PubMed ID: 11259784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetylcysteine attenuates the decline in muscle Na+,K+-pump activity and delays fatigue during prolonged exercise in humans.
    McKenna MJ; Medved I; Goodman CA; Brown MJ; Bjorksten AR; Murphy KT; Petersen AC; Sostaric S; Gong X
    J Physiol; 2006 Oct; 576(Pt 1):279-88. PubMed ID: 16840514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
    Zafar KS; Inayat-Hussain SH; Ross D
    J Neurochem; 2007 Aug; 102(3):913-21. PubMed ID: 17504267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
    Chinta SJ; Andersen JK
    Free Radic Biol Med; 2006 Nov; 41(9):1442-8. PubMed ID: 17023271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothesis: can N-acetylcysteine be beneficial in Parkinson's disease?
    Martínez M; Martínez N; Hernández AI; Ferrándiz ML
    Life Sci; 1999; 64(15):1253-7. PubMed ID: 10227580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease.
    Shen XM; Li H; Dryhurst G
    J Neural Transm (Vienna); 2000; 107(8-9):959-78. PubMed ID: 11041275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice: implications for treatment of Parkinson's disease.
    Martínez Banaclocha M
    Brain Res; 2000 Mar; 859(1):173-5. PubMed ID: 10720628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidation of proteinaceous cysteine residues by dopamine-derived H2O2 in PC12 cells.
    Kim JR; Kwon KS; Yoon HW; Lee SR; Rhee SG
    Arch Biochem Biophys; 2002 Jan; 397(2):414-23. PubMed ID: 11795902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine.
    Möller M; Du Preez JL; Viljoen FP; Berk M; Emsley R; Harvey BH
    Brain Behav Immun; 2013 May; 30():156-67. PubMed ID: 23270677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of lead on oxidative stress, Na+K+ATPase activity and mitochondrial electron transport chain activity of the brain of Clarias batrachus L.
    Maiti AK; Saha NC; Paul G
    Bull Environ Contam Toxicol; 2010 Jun; 84(6):672-6. PubMed ID: 20419287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase.
    Pisani A; Martella G; Tscherter A; Costa C; Mercuri NB; Bernardi G; Shen J; Calabresi P
    Neurobiol Dis; 2006 Jul; 23(1):54-60. PubMed ID: 16624565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity.
    Ajjimaporn A; Shavali S; Ebadi M; Govitrapong P
    Brain Res Bull; 2008 Dec; 77(6):361-6. PubMed ID: 18852031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases.
    Gluck MR; Zeevalk GD
    J Neurochem; 2004 Nov; 91(4):788-95. PubMed ID: 15525332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.